This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Social disorders starting during childhood or adolescence
KRA_PSY_CHILDSOC
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
343 |
4. Check minimum number of eventsNone |
343 |
5. Include endpointsNone |
343 |
6. Filter based on genotype QC (FinnGen only) |
294 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F90-F98
- Name in latin
- Perturbationes functionum socialium specialiter in pueritia incipientes
Similar endpoints
↥List of similar endpoints to
Social disorders starting during childhood or adolescence
based on the number of shared cases.
Similar with more cases:
- Social disorders starting during childhood or adolecense, excluding more controls
- Emotional disorders and disorders of social functioning with onset specific to childhood
- Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
- Any mental disorder
- Psychiatric diseases
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 294 | 167 | 127 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.06 |
| Median age at first event (years) | 11.29 | 12.28 | 10.00 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 321
- Matched controls
- 3210
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F94.0
ICD-10 Finland
Elective mutism
+∞
102.8
93
*
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
+∞
78.4
72
*
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
+∞
76.1
70
*
F94.1
ICD-10 Finland
Reactive attachment disorder of childhood
+∞
61.5
57
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
8.5
52.7
79
119
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.4
48.7
148
440
3138X
ICD-9 Finland
Disturbance of emotions specific to childhood and adolescence, Other or mixed emotional disturbances of childhood or adolescence[MUU MÄÄRITTELTY EMOTIONAALISENA OIREENA ILM. HÄIRIÖ]
+∞
45.9
43
*
N05AH03
ATC
olanzapine; systemic
6.5
42.7
84
167
N05AX08
ATC
risperidone; systemic
6.9
42.3
76
138
N05AH04
ATC
quetiapine; oral
4.3
35.5
140
490
Z2445
NOMESCO Finland
Psychologist
5.4
34.8
83
195
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.7
33.4
59
104
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.4
32.9
76
173
F29
ICD-10 Finland
Unspecified nonorganic psychosis
6.2
32.2
62
119
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
7.6
32.0
49
74
IGV01
NOMESCO Finland
Psychiatric network contact
8.0
31.4
46
66
Z2446
NOMESCO Finland
Social worker
4.8
30.8
85
224
N05AX12
ATC
aripiprazole; systemic
5.7
30.8
65
136
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
6.2
30.2
58
111
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.0
29.3
116
399
F93.89
ICD-10 Finland
Other childhood emotional disorders
7.4
28.9
45
69
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.9
28.1
47
78
N05BA01
ATC
diazepam; systemic, rectal
5.3
27.8
64
144
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.9
27.1
69
169
R5599
NOMESCO Finland
Other rehabilitation service
8.1
26.0
37
51
ZY010
NOMESCO Finland
Hospital outpatient
4.6
25.8
72
190
N06AB03
ATC
fluoxetine; oral
4.4
25.3
75
207
F84.5
ICD-10 Finland
Asperger syndrome
9.4
24.9
31
36
N05AH02
ATC
clozapine; systemic
8.6
24.7
33
42
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.8
24.6
64
159
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
34.1
24.2
31
10
N03AG01
ATC
valproic acid; systemic, rectal
5.4
23.6
51
108
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
9.1
23.5
30
36
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
21.0
23.1
34
18
N05AA02
ATC
levomepromazine; systemic
7.9
22.9
33
46
ZYC01
NOMESCO Finland
Remote contact by phone
4.9
22.2
55
131
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.4
22.1
39
68
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
4.9
21.8
53
124
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
6.6
21.7
37
62
IGY99
NOMESCO Finland
Other psychiatric treatment contact
4.6
20.5
54
135
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.1
20.0
63
180
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
6.0
19.8
37
68
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.6
19.3
50
123
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.5
19.3
52
132
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.2
18.7
56
154
N03AX09
ATC
lamotrigine; oral
4.7
18.6
47
113
Z3231
NOMESCO Finland
Registered nurse
2.9
18.6
135
644
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.4
17.8
49
126
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
5.3
17.8
38
79
N06AX16
ATC
venlafaxine; oral
3.4
17.4
75
264
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.2
17.3
38
81
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.9
17.1
56
164
F94.2
ICD-10 Finland
Disinhibited attachment disorder of childhood
+∞
16.8
16
*
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
19.2
16.8
25
14
N05CF01
ATC
zopiclone; oral
3.4
16.6
72
254
N05AF03
ATC
chlorprothixene; systemic
12.6
16.4
29
25
F20.9
ICD-10 Finland
Schizophrenia, unspecified
7.5
16.3
24
34
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.9
16.3
54
159
N06AB04
ATC
citalopram; systemic
3.5
16.0
62
203
F92.0
ICD-10 Finland
Depressive conduct disorder
20.5
15.8
23
12
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
4.4
15.7
43
110
IGP01
NOMESCO Finland
Psychiatric family contact
4.6
15.3
39
94
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.0
14.9
81
325
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
5.8
14.8
28
52
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
4.1
14.7
44
120
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.5
14.7
56
181
F83
ICD-10 Finland
Mixed specific developmental disorders
6.2
14.7
26
45
IEV99
NOMESCO Finland
Other psychiatric network intervention
6.2
14.7
26
45
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.2
14.6
67
243
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
5.4
14.6
30
60
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.9
14.4
46
132
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
4.5
14.2
37
91
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.0
14.2
75
296
N05BA04
ATC
oxazepam; oral
2.7
14.1
95
426
Z61.8
ICD-10 Finland
Other negative life events in childhood
18.6
14.0
21
12
P74
ICPC
Anxiety disorder/anxiety state
3.3
13.8
59
205
Z2221
NOMESCO Finland
Medical doctor
2.6
13.8
110
537
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
5.9
13.6
25
45
N06AB06
ATC
sertraline; oral
2.8
12.9
79
336
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
4.8
12.9
30
67
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.6
12.8
100
481
Z3226
NOMESCO Finland
Physiotherapist
2.7
12.7
84
372
P99
ICPC
Psychological disorders other
4.4
12.6
33
81
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.9
12.6
40
114
F80.1
ICD-10 Finland
Expressive language disorder
5.7
12.5
24
45
ZXE20
NOMESCO Finland
More than three and less than five hours
3.4
12.1
47
153
K59.09
ICD-10 Finland
Constipation, unspecified
4.6
11.7
29
68
N06AX12
ATC
bupropion; oral
3.0
11.7
57
213
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
10.2
11.4
22
23
N06AX11
ATC
mirtazapine; oral
2.4
11.3
109
573
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
3.5
10.8
39
121
F80.2
ICD-10 Finland
Receptive language disorder
8.5
10.8
23
29
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.6
10.8
37
111
N06BA04
ATC
methylphenidate; oral
2.7
10.6
67
288
N06AX22
ATC
agomelatine; oral
5.7
10.5
20
37
Z61.1
ICD-10 Finland
Removal from home in childhood
113.6
10.5
11
*
3138C
ICD-9 Finland
Disturbance of emotions specific to childhood and adolescence, Other or mixed emotional disturbances of childhood or adolescence[LAPSUUSIÄN RAJATILAHÄIRIÖ]
+∞
10.5
10
*
N06AB05
ATC
paroxetine; oral
4.4
10.1
26
63
N05BA06
ATC
lorazepam; systemic, sublingual
8.1
10.1
22
29
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.6
10.0
24
55
N05BE01
ATC
buspirone; oral
8.2
9.8
21
27
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
9.7
72
333
ZY000
NOMESCO Finland
Hospital inpatient
5.3
9.7
20
40
N07BB01
ATC
disulfiram; oral
5.3
9.7
20
40
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
15.7
9.6
15
10
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.8
9.6
53
212
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.2
9.5
40
137
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.7
9.5
22
49
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
9.1
9.4
19
22
XF400
NOMESCO Finland
ECG with 12 standard connections
2.7
9.4
55
226
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.9
9.4
48
184
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.5
9.2
69
320
P72
ICPC
Schizophrenia
7.4
9.2
21
30
L17
ICPC
Foot/toe symptom/complaint
2.1
9.1
119
697
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.2
9.0
38
130
IEP03
NOMESCO Finland
Focused parental counselling
4.7
9.0
21
47
P29
ICPC
Psychological sympt/compl other
2.4
9.0
74
359
OAB43, ,
SPAT
0.4
8.9
65
1202
F60.9
ICD-10 Finland
Personality disorder, unspecified
8.0
8.8
19
25
K59.0
ICD-10 Finland
Constipation
4.2
8.8
24
61
N06AB10
ATC
escitalopram; oral
2.2
8.8
100
555
S29
ICPC
Skin symptom/complaint other
2.2
8.7
87
458
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.3
8.7
76
378
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
9.4
8.6
17
19
A06AD11
ATC
lactulose; oral
3.4
8.6
32
101
N03AE01
ATC
clonazepam; systemic
4.4
8.6
22
53
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
7.0
8.5
20
30
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
8.5
99
553
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
4.9
8.5
19
41
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
7.4
8.4
19
27
3132C
ICD-9 Finland
Disturbance of emotions specific to childhood and adolescence, Sensitivity, shyness and social withdrawal disorder
+∞
8.4
8
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.4
8.3
21
50
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
4.1
8.3
23
59
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
5.0
8.2
18
38
N05AB03
ATC
perphenazine; systemic, rectal
5.0
8.2
18
38
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.4
8.2
30
94
D11
ICPC
Diarrhoea
2.3
8.1
73
367
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
8.1
111
658
R11
ICD-10 Finland
Nausea and vomiting
2.6
8.0
51
218
D10
ICPC
Vomiting
2.4
7.6
57
263
Z3229
NOMESCO Finland
Other healthcare associate professional
2.9
7.6
38
143
F84.8
ICD-10 Finland
Other pervasive developmental disorders
9.2
7.6
15
17
Z61.9
ICD-10 Finland
Negative life event in childhood, unspecified
25.7
7.6
10
*
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
10.4
7.6
14
14
R4140
NOMESCO Finland
Psychotherapy
10.4
7.6
14
14
K02.1
ICD-10 Finland
Caries of dentine
2.1
7.5
241
1897
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
81.9
7.4
8
*
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
11.2
7.4
13
12
N04AA02
ATC
biperiden; systemic
11.2
7.4
13
12
F93.2
ICD-10 Finland
Social anxiety disorder of childhood
+∞
7.3
7
*
N05CD07
ATC
temazepam; oral
7.6
7.3
16
22
T74.1
ICD-10 Finland
Physical abuse
3.9
7.2
21
56
F40.1
ICD-10 Finland
Social phobias
2.9
7.2
35
130
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
6.3
7.2
18
30
ICB06, ,
NOMESCO Finland
4.2
7.2
19
47
ZXE00
NOMESCO Finland
One hour or less
1.9
7.2
130
842
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
12.4
7.1
12
10
A28
ICPC
Limited function/disability NOS
3.2
7.1
29
97
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
7.3
7.1
16
23
D01
ICPC
Abdominal pain/cramps general
2.1
7.1
76
408
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
6.1
7.0
18
31
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.0
7.0
31
109
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
7.0
32
115
P76
ICPC
Depressive disorder
2.4
7.0
49
220
ZXY03
NOMESCO Finland
Occupational therapist
14.2
6.9
11
8
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
14.2
6.9
11
8
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
6.9
71
374
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
7.0
6.9
16
24
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
11.3
6.9
12
11
N05AD01
ATC
haloperidol; systemic
9.6
6.8
13
14
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
9.6
6.8
13
14
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.7
6.8
22
63
N05AN01
ATC
lithium; oral
4.1
6.8
19
49
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
40.9
6.8
8
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
6.8
57
277
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
6.7
6.7
16
25
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.2
6.7
18
45
F88
ICD-10 Finland
Other disorders of psychological development
8.1
6.7
14
18
N03AX11
ATC
topiramate; oral
3.9
6.5
19
51
IEP99
NOMESCO Finland
Other psychiatric family intervention
3.9
6.5
19
51
R4120
NOMESCO Finland
Occupational therapy
3.0
6.4
29
103
T07
ICPC
Weight gain
4.2
6.4
17
42
RS214, ,
NOMESCO Finland
14.7
6.4
10
7
F21
ICD-10 Finland
Schizotypal disorder
14.7
6.4
10
7
SPAT1240
SPAT
Therapeutic discussion
2.2
6.4
64
333
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.0
6.3
18
47
AA400
NOMESCO Finland
Electroconvulsive therapy
11.3
6.3
11
10
SPAT1260
SPAT
Consultation of another employee
2.2
6.3
59
299
EBA00
NOMESCO Finland
Extraction of tooth
1.8
6.3
168
1214
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
5.2
6.3
18
36
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
5.2
6.3
18
36
N05AF05
ATC
zuclopenthixol; systemic
27.3
6.3
8
*
K04.08
ICD-10 Finland
Other specified pulpit
2.4
6.2
45
204
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
6.2
25
83
N03AX16
ATC
[U] pregabalin
2.5
6.2
39
166
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
6.2
43
192
S10
ICPC
Boil/carbuncle
3.1
6.2
26
89
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
5.7
6.1
16
29
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
6.1
101
630
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
27
39
7.47
18.10
25.0
24.3
1488.37
1424.51
nmol/l
0.10
27
39
159
881
2.59
15.67
5.0
3.4
27.83
31.08
u/l
1.03
151
832
145
826
2.38
12.77
6.6
6.6
37.91
38.50
g/l
0.59
135
786
158
943
2.33
12.40
10.0
10.2
1.22
1.22
mmol/l
0.18
151
891
135
758
2.35
12.16
2.2
1.7
94.00
97.31
pmol/l
0.40
72
403
127
707
2.32
11.55
3.7
4.0
7.96
8.92
mmol/l
1.05
115
640
98
489
2.45
11.41
2.4
1.7
1.52
1.37
%
3.06
91
445
53
194
3.07
11.27
1.7
1.5
1043.96
1009.59
nmol/l
0.11
46
152
166
1041
2.23
11.23
10.0
9.9
1.22
1.22
mmol/l
0.38
150
933
94
475
2.38
10.54
1.9
1.4
16.05
19.71
nmol/l
2.27
86
424
91
461
2.36
10.09
2.3
2.3
155.34
351.06
u/l
0.74
86
445
227
1667
2.24
9.74
9.4
6.2
90.81
85.98
u/l
0.54
211
1571
33
99
3.60
9.60
1.5
1.3
—
—
—
0
0
115
669
2.12
8.94
4.4
3.5
0.16
0.15
e6/l
0.03
84
467
156
1026
2.01
8.60
8.0
5.8
10.10
11.77
umol/l
1.46
143
964
70
337
2.38
8.59
5.7
9.9
1.07
1.19
mmol/l
0.11
63
277
126
787
1.99
7.88
4.4
3.7
—
—
—
0
0
29
96
3.22
7.25
1.7
1.8
—
—
—
0
0
71
371
2.17
7.09
10.9
9.2
1.18
1.21
mmol/l
0.30
65
356
78
424
2.11
7.03
3.4
3.3
0.75
0.59
e6/l
0.42
39
196
61
303
2.25
6.88
5.5
4.2
4.90
8.00
umol/l
1.11
47
242
259
2121
2.14
6.85
5.3
4.2
14.17
14.52
pmol/l
1.62
245
1957
160
1127
1.84
6.63
4.4
3.1
66.43
67.09
nmol/l
0.11
151
1066
213
1641
1.89
6.59
20.3
10.3
3.92
3.82
e9/l
0.31
185
1401
185
1375
1.82
6.31
7.1
6.2
6.11
6.06
mmol/l
0.13
174
1242
74
410
2.05
6.29
3.6
3.5
4.78
2.88
e6/l
0.64
35
184
59
300
2.18
6.26
1.6
1.6
495.24
24632781.27
pmol/l
0.50
51
272
44
198
2.42
6.20
1.4
1.7
0.23
0.26
mg/l
0.15
16
93
49
232
2.31
6.16
7.0
13.4
105.57
105.35
mmol/l
0.15
49
232
104
658
1.86
5.95
3.2
2.7
2.38
2.37
mmol/l
0.03
97
613
51
251
2.23
5.85
2.7
2.9
29.17
30.48
u/l
0.15
41
210
17
46
3.85
5.72
1.4
1.6
—
—
—
0
0
43
200
2.33
5.63
6.7
14.4
1.22
1.28
mmol/l
0.19
43
191
249
2075
1.89
5.36
5.3
2.9
5.79
5.46
mmol/l
2.89
238
1930
229
1902
1.71
4.50
5.2
3.7
36.03
35.96
mmol/mol
0.04
224
1822
17
55
3.21
4.43
1.2
1.4
349.33
354.15
ug/g
—
9
29
14
33
4.39
4.37
9.9
7.8
5.02
4.95
kpa
0.16
14
33
94
628
1.70
4.28
4.6
2.7
51.69
56.16
u/l
0.72
85
583
221
1830
1.67
4.27
6.0
3.5
46.42
30.91
u/l
1.69
211
1770
273
2416
1.87
3.93
6.6
4.9
1.86
1.78
mu/l
0.69
263
2302
297
2717
2.25
3.71
14.0
8.8
31.02
27.54
u/l
0.94
291
2648
52
310
1.81
3.48
2.1
1.8
—
—
—
0
0
91
647
1.57
3.12
3.5
2.6
1.02
1.02
kg/l
0.16
66
400
53
330
1.73
3.06
11.8
14.9
24.71
25.04
mmol/l
0.32
53
330
9
21
4.38
3.01
1.8
1.4
—
—
—
0
0
21
97
2.25
2.84
7.6
11.7
0.59
0.57
%
0.09
21
97
74
514
1.57
2.79
2.2
2.8
0.72
1.09
mg/l
0.93
50
353
95
698
1.51
2.78
3.1
3.0
2.61
2.38
mg/l
0.57
84
610
237
2086
1.52
2.75
16.8
8.4
107.62
106.06
ml/min/173m2
0.51
216
1780
230
2020
1.49
2.62
3.8
2.8
1.36
1.17
mmol/l
2.67
219
1917
22
109
2.09
2.53
1.9
1.6
—
—
—
0
0
15
63
2.45
2.50
2.0
3.6
0.71
9.93
index
—
7
38
52
343
1.62
2.42
4.5
5.0
18.18
11.47
mg/mmol
0.24
30
252
5
8
6.33
2.38
1.0
2.3
—
—
—
0
0
8
22
3.70
2.38
1.0
1.0
1963.75
1445.50
miu/ml
—
8
22
39
241
1.70
2.33
2.2
1.9
4.92
7.04
u/l
1.30
28
169
50
333
1.59
2.24
4.8
2.8
72.50
1321.20
ng/l
1.46
20
149
38
236
1.69
2.23
1.8
1.6
—
—
—
0
0
38
236
1.69
2.23
1.9
1.7
—
—
—
0
0
244
2196
1.46
2.22
4.8
3.3
2.78
2.74
mmol/l
0.35
239
2103
315
3045
2.84
2.22
32.2
16.8
269.87
262.88
e9/l
1.15
303
2980
33
198
1.74
2.19
1.5
1.5
—
—
—
0
0
134
1092
1.39
2.17
1.6
1.7
0.46
2.79
u/ml
3.10
25
245
9
30
3.06
2.16
2.0
3.0
1.09
0.80
e9/l
—
9
30
18
89
2.08
2.10
1.8
1.5
—
—
—
0
0
315
3049
2.77
2.08
32.0
16.7
4.66
4.65
e12/l
0.07
303
2980
70
512
1.47
2.05
3.8
2.4
14.69
16.46
ng/l
0.14
39
205
202
1774
1.37
2.00
5.0
4.1
9.45
6.85
mm/h
2.10
196
1672
19
98
2.00
1.99
6.7
17.2
0.71
0.63
%
0.39
19
98
7
21
3.38
1.97
1.6
1.9
11.14
9.92
umol/l
—
7
21
8
27
3.01
1.95
1.1
1.1
—
—
—
0
0
242
2200
1.41
1.87
4.6
3.2
4.47
4.52
mmol/l
0.40
237
2113
288
2709
1.61
1.86
18.0
10.9
21.45
21.14
mg/l
0.06
233
2064
240
2182
1.40
1.83
4.4
3.1
1.28
1.39
mmol/l
4.79
232
2086
19
102
1.92
1.80
6.9
16.6
2.85
1.20
%
1.60
19
102
31
194
1.66
1.79
1.7
1.8
—
—
—
0
0
28
171
1.70
1.77
4.5
2.2
—
—
—
0
0
19
103
1.90
1.76
7.0
16.5
89.84
94.72
%
0.76
19
103
7
24
2.96
1.73
1.3
1.3
—
—
—
0
0
37
245
1.58
1.72
3.3
4.1
1044.45
542.17
ng/l
0.27
27
191
5
13
3.89
1.72
1.0
2.2
13.12
18.00
umol/l
—
5
13
36
237
1.58
1.72
2.2
1.9
4.76
10.90
iu/l
4.37
26
171
7
25
2.84
1.66
1.3
1.3
—
—
—
0
0
156
1344
1.31
1.63
4.5
3.2
0.00
0.00
estimate
-0.00
31
275
20
115
1.79
1.56
3.4
2.9
75.14
95.35
ml/min/173m2
—
7
40
8
33
2.46
1.54
15.6
3.8
11.86
5.32
pmol/l
—
8
33
50
363
1.45
1.53
3.1
2.7
20228.27
5515.34
u/l
0.63
15
153
44
313
1.47
1.50
1.0
1.1
—
—
—
0
0
41
288
1.49
1.48
2.5
2.2
2.42
2.41
mmol/l
0.30
34
257
24
149
1.66
1.46
1.9
1.8
—
—
—
0
0
20
119
1.73
1.41
1.5
1.6
111.71
116.25
au/ml
—
7
41
28
413
0.65
1.40
1.4
1.6
4.12
3.47
ratio
0.94
19
294
122
1035
1.29
1.38
3.0
2.4
—
—
—
0
0
9
42
2.18
1.34
2.7
2.8
8.44
10.17
%
—
9
42
152
1331
1.27
1.32
4.5
3.2
0.00
0.00
estimate
-0.00
31
288
6
133
0.44
1.31
1.3
1.0
1.27
1.47
g/l
—
6
133
8
36
2.25
1.25
1.1
1.1
—
—
—
0
0
6
25
2.43
1.25
1.7
1.5
—
—
—
0
0
101
846
1.28
1.24
2.2
1.8
1.59
1.30
mmol/l
1.49
96
767
9
45
2.03
1.24
1.7
1.7
—
—
—
0
0
16
93
1.76
1.23
2.1
2.1
36.25
38.85
u/l
0.37
16
88
153
1353
1.25
1.19
4.7
3.3
0.00
0.00
estimate
-0.00
31
269
18
110
1.67
1.18
1.9
2.1
2.40
4.64
iu/ml
—
6
21
22
328
0.65
1.17
1.5
1.5
3.46
3.35
mmol/l
0.15
14
214
43
321
1.39
1.15
3.4
4.1
29.39
29.85
s
0.32
43
315
38
278
1.42
1.14
7.9
6.5
0.77
1.07
mmol/l
0.28
28
207
19
119
1.63
1.14
1.5
1.5
—
—
—
0
0
8
41
1.98
1.09
2.6
3.0
—
—
—
0
0
5
21
2.40
1.09
1.4
2.9
—
—
—
0
0
5
21
2.40
1.09
1.4
2.9
—
—
—
0
0
172
1551
1.23
1.09
4.4
3.6
72.95
61.93
ug/l
0.55
166
1480
7
32
2.21
1.08
1.7
1.9
—
—
—
0
0
34
247
1.42
1.07
1.6
1.2
—
—
—
0
0
21
138
1.56
1.06
1.4
1.6
—
—
—
0
0
5
22
2.29
1.03
1.0
1.5
—
—
—
0
0
5
22
2.29
1.03
1.0
1.0
—
—
—
0
0
9
48
1.90
1.01
3.8
4.8
6.98
7.01
u/ml
—
9
48
7
35
2.02
1.00
4.1
1.8
—
—
—
0
0
9
51
1.79
0.95
1.0
1.2
—
—
—
0
0
38
491
0.74
0.94
1.6
1.6
1254.73
962.22
mu/l
0.90
32
440
6
27
2.24
0.94
1.3
1.1
—
—
—
0
0
6
27
2.24
0.94
1.3
1.1
—
—
—
0
0
6
27
2.24
0.94
1.5
1.1
—
—
—
0
0
6
27
2.24
0.94
1.2
1.1
—
—
—
0
0
6
27
2.24
0.94
1.3
1.1
—
—
—
0
0
23
160
1.47
0.92
3.2
5.0
89.96
95.87
%
0.51
23
160
20
136
1.50
0.89
8.0
3.7
—
—
—
0
0
6
30
2.02
0.87
1.5
1.1
—
—
—
0
0
6
30
2.02
0.87
1.2
1.2
—
—
—
0
0
8
44
1.84
0.86
1.4
1.4
—
—
—
0
0
82
699
1.23
0.86
3.5
2.4
—
—
—
0
0
8
45
1.80
0.85
1.4
1.7
—
—
—
0
0
8
45
1.80
0.85
2.5
2.9
220.75
204.48
e6/l
—
8
29
23
163
1.44
0.84
1.7
1.4
—
—
—
0
0
12
189
0.62
0.84
2.0
2.0
—
—
—
0
0
124
1105
1.20
0.83
3.4
3.0
—
—
estimate
—
0
0
8
46
1.76
0.83
1.9
2.8
592.38
512.29
e6/l
—
8
28
19
130
1.49
0.83
2.4
2.4
0.11
0.15
e6/l
0.26
19
123
51
414
1.28
0.81
1.5
1.3
8.60
14.87
iu/ml
—
10
94
10
58
1.75
0.80
1.3
1.2
—
—
—
0
0
14
210
0.65
0.80
1.9
1.7
—
—
—
0
0
11
66
1.69
0.79
2.5
2.3
—
—
—
0
0
11
66
1.69
0.79
1.3
1.2
—
—
—
0
0
22
157
1.43
0.79
1.3
1.6
197.00
181.17
u/ml
0.16
12
81
124
1111
1.19
0.77
3.4
2.5
—
—
—
0
0
9
53
1.72
0.76
3.6
2.2
120.89
135.23
g/l
—
9
47
8
133
0.59
0.75
1.6
1.0
0.75
0.89
g/l
—
8
133
71
606
1.22
0.74
3.4
2.2
—
—
—
0
0
7
38
1.86
0.74
1.0
1.1
—
—
—
0
0
7
39
1.81
0.73
1.1
1.6
—
—
—
0
0
10
60
1.69
0.73
1.2
1.1
—
—
—
0
0
10
60
1.69
0.73
1.3
1.4
—
—
—
0
0
10
60
1.69
0.73
1.2
1.1
—
—
—
0
0
16
228
0.69
0.72
1.8
1.7
—
—
—
0
0
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
256
2655
0.82
0.68
4.5
4.1
—
—
—
0
0
5
28
1.80
0.66
1.6
1.3
—
—
—
0
0
5
28
1.80
0.66
1.6
1.5
—
—
—
0
0
11
70
1.59
0.66
1.6
1.6
—
—
—
0
0
39
476
0.79
0.65
1.7
1.6
—
—
—
0
0
5
29
1.74
0.64
1.4
1.4
—
—
—
0
0
8
53
1.52
0.59
2.4
1.9
—
—
—
0
0
6
37
1.63
0.56
1.0
1.1
—
—
—
0
0
6
37
1.63
0.56
1.0
1.1
—
—
—
0
0
11
74
1.50
0.54
2.1
1.6
—
—
—
0
0
9
62
1.46
0.53
2.2
2.2
—
—
—
0
0
6
39
1.55
0.53
1.3
2.3
—
—
—
0
0
7
108
0.64
0.49
1.0
1.1
—
14.17
—
0
26
23
183
1.28
0.46
1.0
1.2
1.37
5.50
u/ml
2.96
15
134
14
103
1.38
0.46
1.2
1.1
—
—
—
0
0
75
673
1.15
0.45
4.3
3.2
0.00
0.00
estimate
0.50
29
274
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
8
56
1.44
0.43
2.4
1.6
—
—
—
0
0
22
268
0.81
0.39
1.5
1.5
96.99
61.28
ug/l
0.93
16
240
65
586
1.14
0.37
3.0
2.6
—
—
—
0
0
34
291
1.19
0.37
1.2
1.4
101.83
144.38
u/ml
0.23
12
108
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
20
244
0.81
0.36
1.5
1.5
1.69
1.14
ratio
—
8
161
6
42
1.44
0.35
1.5
1.4
—
—
—
0
0
14
110
1.29
0.32
1.9
1.8
1.18
1.17
g/l
0.00
14
105
22
184
1.21
0.31
1.0
1.2
5.49
2.80
u/ml
0.24
14
123
28
322
0.86
0.29
1.5
1.4
—
—
—
0
0
12
150
0.79
0.27
1.0
1.2
—
4.84
—
0
14
11
139
0.78
0.27
1.5
1.2
—
—
—
0
0
9
72
1.26
0.26
3.6
3.3
0.58
0.62
nmol/l
—
9
63
21
244
0.85
0.25
1.5
1.5
0.96
0.93
ratio
—
9
161
21
244
0.85
0.25
1.5
1.5
1.07
1.21
ratio
—
9
161
21
180
1.18
0.24
1.0
1.2
0.42
0.62
u/ml
0.30
15
114
5
38
1.32
0.23
2.4
1.4
—
—
—
0
0
12
97
1.25
0.23
1.8
1.2
—
—
—
0
0
23
200
1.16
0.23
1.0
1.2
1.13
3.59
u/ml
1.29
14
136
25
219
1.15
0.23
1.2
1.4
195.13
267.97
miu/ml
—
6
117
20
172
1.17
0.22
3.6
2.4
32.40
30.97
%
0.24
15
127
5
41
1.22
0.22
1.0
1.4
43.32
33.07
nmol/l
—
5
35
16
188
0.84
0.22
1.6
1.6
50.79
58.30
ug/l
0.31
16
188
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
79.88
—
0
11
0
14
0.00
0.20
0.0
1.1
—
46.64
—
0
14
9
114
0.78
0.20
1.0
1.1
—
8.01
—
0
22
7
58
1.21
0.18
2.1
1.4
—
—
—
0
0
122
1265
0.94
0.18
2.5
2.0
—
—
—
0
0
101
969
1.06
0.17
4.1
2.8
0.00
0.01
estimate
0.80
27
249
12
101
1.20
0.17
1.4
2.4
1.34
5.51
iu/l
—
6
42
6
78
0.76
0.15
1.2
1.7
—
—
—
0
0
14
160
0.87
0.14
1.4
1.3
—
—
—
0
0
9
106
0.84
0.13
1.8
1.8
—
—
—
0
0
6
57
1.05
0.08
1.2
1.5
3.65
5.87
umol/l
—
6
50
41
392
1.05
0.08
1.6
1.2
4.61
5.91
u/ml
—
10
159
8
75
1.07
0.07
1.0
1.1
—
139.56
—
0
25
9
84
1.07
0.07
1.6
1.1
—
—
—
0
0
9
86
1.05
0.07
1.6
1.1
—
—
—
0
0
75
767
0.97
0.05
4.5
2.5
0.00
0.00
estimate
0.50
26
247
23
238
0.96
0.02
1.4
1.5
—
—
—
0
0
13
125
1.04
0.00
1.0
1.1
0.10
0.44
u/ml
—
6
54
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
2640.00
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.3
—
34.00
—
0
8
8
87
0.92
-0.00
1.0
1.1
—
2.82
—
0
9
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.0
—
32.67
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
59
1.02
-0.00
1.2
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
16.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
88
0.91
-0.00
1.6
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
7.0
—
6.03
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: KRA_PSY_CHILDSOC – Social disorders starting during childhood or adolescence
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).